Follow us on LinkedIn - https://www.linkedin.com/company/fatty-liver-alliance/
There are a number of available tests being used and often in combination, to identify more advanced liver disease.
Dr. Manal Abdelmalek, Hepatologist, Professor of Medicine at Duke University shares her expert opinion about what patients should ask their Primary Care Physician to ensure that their liver disease risks are assessed and that they are referred to a specialist for a more detailed evaluation if warranted.
Dr. Manal Abdelmalek, Hepatologist, Professor of Medicine at Duke University shares her concerns about the challenge of reaching 10M people about fatty liver disease, and the education required to ensure that those needing to seek assessment and treatment by a specialist, receive what they need.
Of the 363 million adults in North America, about 91 million may have fatty liver disease and not know it. How will we screen for that? Should we screen for that? Who is most at risk? All critical questions that need to be addressed.
Dr. Robert Gish discusses current screening options and benefits.
Dr. Manal Abdelmalek, Hepatologist, Professor of Medicine at Duke University shares her recommendations for what would be needed before screening the very high number of fatty liver patients at the Primary Care Physician level.
Dr. Manal Abdelmalek, Hepatologist, Professor of Medicine at Duke University discusses the multiple risk factors of more advanced fatty liver disease. For those with multiple risk factors, as shared in this video, the advice is to speak with your Primary Care Physician so that you could be assessed.
Nurse Practitioner, Cheryl Dale shows how easy a Fibroscan can be for patients and that there is nothing to be afraid of.
Dr. Mark Swain explains what your Physician uses to diagnose NASH. There are specific markers that are considered.
Dr. Supriya Joshi clearly explains how nonalcoholic fatty liver disease (NAFLD ) and nonalcoholic steatohepatitis (NASH) are different.